Pinned
Exciting news from KAIMRC!
Our Drug Discovery Program has just published a paper entitled “First-in-class inhibitors of Nsp15 endoribonuclease of SARS-CoV-2: modeling, synthesis, and enzymatic assay of thiazolidinedione and rhodanine analogs” in JBC, one of the world’s leading
00:00



